Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
- PMID: 19925672
- PMCID: PMC2785804
- DOI: 10.1186/1756-6606-2-35
Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
Abstract
Background: Glycogen synthase kinase-3 (GSK-3) is a widely expressed and highly conserved serine/threonine protein kinase encoded by two genes that generate two related proteins: GSK-3alpha and GSK-3beta. Mice lacking a functional GSK-3alpha gene were engineered in our laboratory; they are viable and display insulin sensitivity. In this study, we have characterized brain functions of GSK-3alpha KO mice by using a well-established battery of behavioral tests together with neurochemical and neuroanatomical analysis.
Results: Similar to the previously described behaviours of GSK-3beta(+/-) mice, GSK-3alpha mutants display decreased exploratory activity, decreased immobility time and reduced aggressive behavior. However, genetic inactivation of the GSK-3alpha gene was associated with: decreased locomotion and impaired motor coordination, increased grooming activity, loss of social motivation and novelty; enhanced sensorimotor gating and impaired associated memory and coordination. GSK-3alpha KO mice exhibited a deficit in fear conditioning, however memory formation as assessed by a passive avoidance test was normal, suggesting that the animals are sensitized for active avoidance of a highly aversive stimulus in the fear-conditioning paradigm. Changes in cerebellar structure and function were observed in mutant mice along with a significant decrease of the number and size of Purkinje cells.
Conclusion: Taken together, these data support a role for the GSK-3alpha gene in CNS functioning and possible involvement in the development of psychiatric disorders.
Figures







Similar articles
-
Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.Cell Metab. 2007 Oct;6(4):329-37. doi: 10.1016/j.cmet.2007.08.013. Cell Metab. 2007. PMID: 17908561
-
The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.Biomed Pharmacother. 2020 Aug;128:110249. doi: 10.1016/j.biopha.2020.110249. Epub 2020 May 26. Biomed Pharmacother. 2020. PMID: 32470749
-
Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.Mol Cell Biol. 2008 Oct;28(20):6314-28. doi: 10.1128/MCB.00763-08. Epub 2008 Aug 11. Mol Cell Biol. 2008. PMID: 18694957 Free PMC article.
-
Emerging roles of GSK-3α in pathophysiology: Emphasis on cardio-metabolic disorders.Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118616. doi: 10.1016/j.bbamcr.2019.118616. Epub 2019 Nov 27. Biochim Biophys Acta Mol Cell Res. 2020. PMID: 31785335 Review.
-
Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain.J Pharmacol Sci. 2009 Feb;109(2):174-8. doi: 10.1254/jphs.08r29fm. Epub 2009 Jan 29. J Pharmacol Sci. 2009. PMID: 19179803 Review.
Cited by
-
Recent Advances on the Role of GSK3β in the Pathogenesis of Amyotrophic Lateral Sclerosis.Brain Sci. 2020 Sep 26;10(10):675. doi: 10.3390/brainsci10100675. Brain Sci. 2020. PMID: 32993098 Free PMC article. Review.
-
Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase.Front Mol Neurosci. 2012 Jul 16;5:80. doi: 10.3389/fnmol.2012.00080. eCollection 2012. Front Mol Neurosci. 2012. PMID: 22811658 Free PMC article.
-
Glycogen synthase kinase-3 signaling in Alzheimer's disease.Biochim Biophys Acta Mol Cell Res. 2020 May;1867(5):118664. doi: 10.1016/j.bbamcr.2020.118664. Epub 2020 Jan 30. Biochim Biophys Acta Mol Cell Res. 2020. PMID: 32006534 Free PMC article. Review.
-
CaMKK2 as an emerging treatment target for bipolar disorder.Mol Psychiatry. 2023 Nov;28(11):4500-4511. doi: 10.1038/s41380-023-02260-3. Epub 2023 Sep 20. Mol Psychiatry. 2023. PMID: 37730845 Free PMC article. Review.
-
An expanding GSK3 network: implications for aging research.Geroscience. 2019 Aug;41(4):369-382. doi: 10.1007/s11357-019-00085-z. Epub 2019 Jul 17. Geroscience. 2019. PMID: 31313216 Free PMC article. Review.
References
-
- Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem. 1980;107(2):519–527. - PubMed
-
- Woodgett JR, Cohen P. Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5) Biochim Biophys Acta. 1984;788(3):339–347. - PubMed
-
- Ferrer I, Barrachina M, Puig B. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 2002;104(6):583–591. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials